Medical Care

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

The global market for Viral Vector Manufacturing CDMO Services was valued at US$ 5231 million in the year 2023 and is projected to reach a revised size of US$ 9450 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Viral Vector Manufacturing CDMO services refer to providing professional viral vector production and development services to biopharmaceutical companies. These viral vectors are usually used in gene therapy, vaccine development, cell therapy and other fields. CDMO organizations are responsible for the design and optimization of viral vectors to large-scale production in accordance with GMP standards, ensuring the safety and effectiveness of the products, while strictly controlling the quality of each production link. These services provide key technical support for biopharmaceutical companies to help accelerate the development and commercialization of their products.
North American market for Viral Vector Manufacturing CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Manufacturing CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Vector Manufacturing CDMO Services in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Vector Manufacturing CDMO Services include Thermo Fisher Scientific Inc., Revvity, Charles River Laboratories, AGC Inc. Group (AGC Biologics), NorthX Biologics, Lonza, Avid Bioservices, Inc., Exothera, Merck KGaA, Batavia Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Manufacturing CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Manufacturing CDMO Services.
The Viral Vector Manufacturing CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector Manufacturing CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Manufacturing CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Revvity
Charles River Laboratories
AGC Inc. Group (AGC Biologics)
NorthX Biologics
Lonza
Avid Bioservices, Inc.
Exothera
Merck KGaA
Batavia Biosciences
SK pharmteco Inc.
Biovian
Curia Vector Technology
Esco Aster
ABL, Inc.
Genezen
Pharmaron
Roche AG
FinVector
FUJIFILM Diosynth Biotechnologies
Kaneka Eurogentec S.A. (Kaneka Corporation)
Oxford Biomedica plc
Sanofi S.A.
Segment by Type
Adeno-associated Virus
Lentivirus
Retrovirus
Adenovirus
Other
Segment by Application
Gene Therapy
Vaccine Development
Cell Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Manufacturing CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adeno-associated Virus
1.2.3 Lentivirus
1.2.4 Retrovirus
1.2.5 Adenovirus
1.2.6 Other
1.3 Market by Application
1.3.1 Global Viral Vector Manufacturing CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Vaccine Development
1.3.4 Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Manufacturing CDMO Services Market Perspective (2019-2030)
2.2 Global Viral Vector Manufacturing CDMO Services Growth Trends by Region
2.2.1 Global Viral Vector Manufacturing CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector Manufacturing CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector Manufacturing CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector Manufacturing CDMO Services Market Dynamics
2.3.1 Viral Vector Manufacturing CDMO Services Industry Trends
2.3.2 Viral Vector Manufacturing CDMO Services Market Drivers
2.3.3 Viral Vector Manufacturing CDMO Services Market Challenges
2.3.4 Viral Vector Manufacturing CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing CDMO Services Players by Revenue
3.1.1 Global Top Viral Vector Manufacturing CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector Manufacturing CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Manufacturing CDMO Services Revenue
3.4 Global Viral Vector Manufacturing CDMO Services Market Concentration Ratio
3.4.1 Global Viral Vector Manufacturing CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing CDMO Services Revenue in 2023
3.5 Global Key Players of Viral Vector Manufacturing CDMO Services Head office and Area Served
3.6 Global Key Players of Viral Vector Manufacturing CDMO Services, Product and Application
3.7 Global Key Players of Viral Vector Manufacturing CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Manufacturing CDMO Services Breakdown Data by Type
4.1 Global Viral Vector Manufacturing CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Type (2025-2030)
5 Viral Vector Manufacturing CDMO Services Breakdown Data by Application
5.1 Global Viral Vector Manufacturing CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector Manufacturing CDMO Services Market Size (2019-2030)
6.2 North America Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)
6.4 North America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Manufacturing CDMO Services Market Size (2019-2030)
7.2 Europe Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)
7.4 Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Manufacturing CDMO Services Market Size (2019-2030)
9.2 Latin America Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Viral Vector Manufacturing CDMO Services Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Revvity
11.2.1 Revvity Company Details
11.2.2 Revvity Business Overview
11.2.3 Revvity Viral Vector Manufacturing CDMO Services Introduction
11.2.4 Revvity Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.2.5 Revvity Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Viral Vector Manufacturing CDMO Services Introduction
11.3.4 Charles River Laboratories Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 AGC Inc. Group (AGC Biologics)
11.4.1 AGC Inc. Group (AGC Biologics) Company Details
11.4.2 AGC Inc. Group (AGC Biologics) Business Overview
11.4.3 AGC Inc. Group (AGC Biologics) Viral Vector Manufacturing CDMO Services Introduction
11.4.4 AGC Inc. Group (AGC Biologics) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.4.5 AGC Inc. Group (AGC Biologics) Recent Development
11.5 NorthX Biologics
11.5.1 NorthX Biologics Company Details
11.5.2 NorthX Biologics Business Overview
11.5.3 NorthX Biologics Viral Vector Manufacturing CDMO Services Introduction
11.5.4 NorthX Biologics Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.5.5 NorthX Biologics Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Viral Vector Manufacturing CDMO Services Introduction
11.6.4 Lonza Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 Avid Bioservices, Inc.
11.7.1 Avid Bioservices, Inc. Company Details
11.7.2 Avid Bioservices, Inc. Business Overview
11.7.3 Avid Bioservices, Inc. Viral Vector Manufacturing CDMO Services Introduction
11.7.4 Avid Bioservices, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.7.5 Avid Bioservices, Inc. Recent Development
11.8 Exothera
11.8.1 Exothera Company Details
11.8.2 Exothera Business Overview
11.8.3 Exothera Viral Vector Manufacturing CDMO Services Introduction
11.8.4 Exothera Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.8.5 Exothera Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Viral Vector Manufacturing CDMO Services Introduction
11.9.4 Merck KGaA Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Batavia Biosciences
11.10.1 Batavia Biosciences Company Details
11.10.2 Batavia Biosciences Business Overview
11.10.3 Batavia Biosciences Viral Vector Manufacturing CDMO Services Introduction
11.10.4 Batavia Biosciences Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.10.5 Batavia Biosciences Recent Development
11.11 SK pharmteco Inc.
11.11.1 SK pharmteco Inc. Company Details
11.11.2 SK pharmteco Inc. Business Overview
11.11.3 SK pharmteco Inc. Viral Vector Manufacturing CDMO Services Introduction
11.11.4 SK pharmteco Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.11.5 SK pharmteco Inc. Recent Development
11.12 Biovian
11.12.1 Biovian Company Details
11.12.2 Biovian Business Overview
11.12.3 Biovian Viral Vector Manufacturing CDMO Services Introduction
11.12.4 Biovian Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.12.5 Biovian Recent Development
11.13 Curia Vector Technology
11.13.1 Curia Vector Technology Company Details
11.13.2 Curia Vector Technology Business Overview
11.13.3 Curia Vector Technology Viral Vector Manufacturing CDMO Services Introduction
11.13.4 Curia Vector Technology Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.13.5 Curia Vector Technology Recent Development
11.14 Esco Aster
11.14.1 Esco Aster Company Details
11.14.2 Esco Aster Business Overview
11.14.3 Esco Aster Viral Vector Manufacturing CDMO Services Introduction
11.14.4 Esco Aster Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.14.5 Esco Aster Recent Development
11.15 ABL, Inc.
11.15.1 ABL, Inc. Company Details
11.15.2 ABL, Inc. Business Overview
11.15.3 ABL, Inc. Viral Vector Manufacturing CDMO Services Introduction
11.15.4 ABL, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.15.5 ABL, Inc. Recent Development
11.16 Genezen
11.16.1 Genezen Company Details
11.16.2 Genezen Business Overview
11.16.3 Genezen Viral Vector Manufacturing CDMO Services Introduction
11.16.4 Genezen Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.16.5 Genezen Recent Development
11.17 Pharmaron
11.17.1 Pharmaron Company Details
11.17.2 Pharmaron Business Overview
11.17.3 Pharmaron Viral Vector Manufacturing CDMO Services Introduction
11.17.4 Pharmaron Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.17.5 Pharmaron Recent Development
11.18 Roche AG
11.18.1 Roche AG Company Details
11.18.2 Roche AG Business Overview
11.18.3 Roche AG Viral Vector Manufacturing CDMO Services Introduction
11.18.4 Roche AG Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.18.5 Roche AG Recent Development
11.19 FinVector
11.19.1 FinVector Company Details
11.19.2 FinVector Business Overview
11.19.3 FinVector Viral Vector Manufacturing CDMO Services Introduction
11.19.4 FinVector Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.19.5 FinVector Recent Development
11.20 FUJIFILM Diosynth Biotechnologies
11.20.1 FUJIFILM Diosynth Biotechnologies Company Details
11.20.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.20.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Introduction
11.20.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.20.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.21 Kaneka Eurogentec S.A. (Kaneka Corporation)
11.21.1 Kaneka Eurogentec S.A. (Kaneka Corporation) Company Details
11.21.2 Kaneka Eurogentec S.A. (Kaneka Corporation) Business Overview
11.21.3 Kaneka Eurogentec S.A. (Kaneka Corporation) Viral Vector Manufacturing CDMO Services Introduction
11.21.4 Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.21.5 Kaneka Eurogentec S.A. (Kaneka Corporation) Recent Development
11.22 Oxford Biomedica plc
11.22.1 Oxford Biomedica plc Company Details
11.22.2 Oxford Biomedica plc Business Overview
11.22.3 Oxford Biomedica plc Viral Vector Manufacturing CDMO Services Introduction
11.22.4 Oxford Biomedica plc Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.22.5 Oxford Biomedica plc Recent Development
11.23 Sanofi S.A.
11.23.1 Sanofi S.A. Company Details
11.23.2 Sanofi S.A. Business Overview
11.23.3 Sanofi S.A. Viral Vector Manufacturing CDMO Services Introduction
11.23.4 Sanofi S.A. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)
11.23.5 Sanofi S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adeno-associated Virus
Table 3. Key Players of Lentivirus
Table 4. Key Players of Retrovirus
Table 5. Key Players of Adenovirus
Table 6. Key Players of Other
Table 7. Global Viral Vector Manufacturing CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Vector Manufacturing CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Viral Vector Manufacturing CDMO Services Market Share by Region (2019-2024)
Table 11. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Viral Vector Manufacturing CDMO Services Market Share by Region (2025-2030)
Table 13. Viral Vector Manufacturing CDMO Services Market Trends
Table 14. Viral Vector Manufacturing CDMO Services Market Drivers
Table 15. Viral Vector Manufacturing CDMO Services Market Challenges
Table 16. Viral Vector Manufacturing CDMO Services Market Restraints
Table 17. Global Viral Vector Manufacturing CDMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Viral Vector Manufacturing CDMO Services Market Share by Players (2019-2024)
Table 19. Global Top Viral Vector Manufacturing CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing CDMO Services as of 2023)
Table 20. Ranking of Global Top Viral Vector Manufacturing CDMO Services Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing CDMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Viral Vector Manufacturing CDMO Services, Headquarters and Area Served
Table 23. Global Key Players of Viral Vector Manufacturing CDMO Services, Product and Application
Table 24. Global Key Players of Viral Vector Manufacturing CDMO Services, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector Manufacturing CDMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Type (2019-2024)
Table 28. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Type (2025-2030)
Table 30. Global Viral Vector Manufacturing CDMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Application (2019-2024)
Table 32. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Application (2025-2030)
Table 34. North America Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 49. Thermo Fisher Scientific Inc. Company Details
Table 50. Thermo Fisher Scientific Inc. Business Overview
Table 51. Thermo Fisher Scientific Inc. Viral Vector Manufacturing CDMO Services Product
Table 52. Thermo Fisher Scientific Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 53. Thermo Fisher Scientific Inc. Recent Development
Table 54. Revvity Company Details
Table 55. Revvity Business Overview
Table 56. Revvity Viral Vector Manufacturing CDMO Services Product
Table 57. Revvity Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 58. Revvity Recent Development
Table 59. Charles River Laboratories Company Details
Table 60. Charles River Laboratories Business Overview
Table 61. Charles River Laboratories Viral Vector Manufacturing CDMO Services Product
Table 62. Charles River Laboratories Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 63. Charles River Laboratories Recent Development
Table 64. AGC Inc. Group (AGC Biologics) Company Details
Table 65. AGC Inc. Group (AGC Biologics) Business Overview
Table 66. AGC Inc. Group (AGC Biologics) Viral Vector Manufacturing CDMO Services Product
Table 67. AGC Inc. Group (AGC Biologics) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 68. AGC Inc. Group (AGC Biologics) Recent Development
Table 69. NorthX Biologics Company Details
Table 70. NorthX Biologics Business Overview
Table 71. NorthX Biologics Viral Vector Manufacturing CDMO Services Product
Table 72. NorthX Biologics Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 73. NorthX Biologics Recent Development
Table 74. Lonza Company Details
Table 75. Lonza Business Overview
Table 76. Lonza Viral Vector Manufacturing CDMO Services Product
Table 77. Lonza Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 78. Lonza Recent Development
Table 79. Avid Bioservices, Inc. Company Details
Table 80. Avid Bioservices, Inc. Business Overview
Table 81. Avid Bioservices, Inc. Viral Vector Manufacturing CDMO Services Product
Table 82. Avid Bioservices, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 83. Avid Bioservices, Inc. Recent Development
Table 84. Exothera Company Details
Table 85. Exothera Business Overview
Table 86. Exothera Viral Vector Manufacturing CDMO Services Product
Table 87. Exothera Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 88. Exothera Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Viral Vector Manufacturing CDMO Services Product
Table 92. Merck KGaA Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Batavia Biosciences Company Details
Table 95. Batavia Biosciences Business Overview
Table 96. Batavia Biosciences Viral Vector Manufacturing CDMO Services Product
Table 97. Batavia Biosciences Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 98. Batavia Biosciences Recent Development
Table 99. SK pharmteco Inc. Company Details
Table 100. SK pharmteco Inc. Business Overview
Table 101. SK pharmteco Inc. Viral Vector Manufacturing CDMO Services Product
Table 102. SK pharmteco Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 103. SK pharmteco Inc. Recent Development
Table 104. Biovian Company Details
Table 105. Biovian Business Overview
Table 106. Biovian Viral Vector Manufacturing CDMO Services Product
Table 107. Biovian Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 108. Biovian Recent Development
Table 109. Curia Vector Technology Company Details
Table 110. Curia Vector Technology Business Overview
Table 111. Curia Vector Technology Viral Vector Manufacturing CDMO Services Product
Table 112. Curia Vector Technology Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 113. Curia Vector Technology Recent Development
Table 114. Esco Aster Company Details
Table 115. Esco Aster Business Overview
Table 116. Esco Aster Viral Vector Manufacturing CDMO Services Product
Table 117. Esco Aster Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 118. Esco Aster Recent Development
Table 119. ABL, Inc. Company Details
Table 120. ABL, Inc. Business Overview
Table 121. ABL, Inc. Viral Vector Manufacturing CDMO Services Product
Table 122. ABL, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 123. ABL, Inc. Recent Development
Table 124. Genezen Company Details
Table 125. Genezen Business Overview
Table 126. Genezen Viral Vector Manufacturing CDMO Services Product
Table 127. Genezen Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 128. Genezen Recent Development
Table 129. Pharmaron Company Details
Table 130. Pharmaron Business Overview
Table 131. Pharmaron Viral Vector Manufacturing CDMO Services Product
Table 132. Pharmaron Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 133. Pharmaron Recent Development
Table 134. Roche AG Company Details
Table 135. Roche AG Business Overview
Table 136. Roche AG Viral Vector Manufacturing CDMO Services Product
Table 137. Roche AG Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 138. Roche AG Recent Development
Table 139. FinVector Company Details
Table 140. FinVector Business Overview
Table 141. FinVector Viral Vector Manufacturing CDMO Services Product
Table 142. FinVector Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 143. FinVector Recent Development
Table 144. FUJIFILM Diosynth Biotechnologies Company Details
Table 145. FUJIFILM Diosynth Biotechnologies Business Overview
Table 146. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Product
Table 147. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 148. FUJIFILM Diosynth Biotechnologies Recent Development
Table 149. Kaneka Eurogentec S.A. (Kaneka Corporation) Company Details
Table 150. Kaneka Eurogentec S.A. (Kaneka Corporation) Business Overview
Table 151. Kaneka Eurogentec S.A. (Kaneka Corporation) Viral Vector Manufacturing CDMO Services Product
Table 152. Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 153. Kaneka Eurogentec S.A. (Kaneka Corporation) Recent Development
Table 154. Oxford Biomedica plc Company Details
Table 155. Oxford Biomedica plc Business Overview
Table 156. Oxford Biomedica plc Viral Vector Manufacturing CDMO Services Product
Table 157. Oxford Biomedica plc Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 158. Oxford Biomedica plc Recent Development
Table 159. Sanofi S.A. Company Details
Table 160. Sanofi S.A. Business Overview
Table 161. Sanofi S.A. Viral Vector Manufacturing CDMO Services Product
Table 162. Sanofi S.A. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)
Table 163. Sanofi S.A. Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
Table 167. Authors List of This Report


List of Figures
Figure 1. Viral Vector Manufacturing CDMO Services Picture
Figure 2. Global Viral Vector Manufacturing CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Viral Vector Manufacturing CDMO Services Market Share by Type: 2023 VS 2030
Figure 4. Adeno-associated Virus Features
Figure 5. Lentivirus Features
Figure 6. Retrovirus Features
Figure 7. Adenovirus Features
Figure 8. Other Features
Figure 9. Global Viral Vector Manufacturing CDMO Services Market Size by Application (2024-2030) & (US$ Million)
Figure 10. Global Viral Vector Manufacturing CDMO Services Market Share by Application: 2023 VS 2030
Figure 11. Gene Therapy Case Studies
Figure 12. Vaccine Development Case Studies
Figure 13. Cell Therapy Case Studies
Figure 14. Viral Vector Manufacturing CDMO Services Report Years Considered
Figure 15. Global Viral Vector Manufacturing CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Viral Vector Manufacturing CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Viral Vector Manufacturing CDMO Services Market Share by Region: 2023 VS 2030
Figure 18. Global Viral Vector Manufacturing CDMO Services Market Share by Players in 2023
Figure 19. Global Top Viral Vector Manufacturing CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing CDMO Services as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing CDMO Services Revenue in 2023
Figure 21. North America Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)
Figure 23. United States Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)
Figure 27. Germany Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Share by Region (2019-2030)
Figure 35. China Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)
Figure 43. Mexico Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)
Figure 47. Turkey Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 51. Revvity Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 52. Charles River Laboratories Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 53. AGC Inc. Group (AGC Biologics) Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 54. NorthX Biologics Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 55. Lonza Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 56. Avid Bioservices, Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 57. Exothera Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 58. Merck KGaA Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 59. Batavia Biosciences Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 60. SK pharmteco Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 61. Biovian Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 62. Curia Vector Technology Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 63. Esco Aster Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 64. ABL, Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 65. Genezen Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 66. Pharmaron Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 67. Roche AG Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 68. FinVector Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 69. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 70. Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 71. Oxford Biomedica plc Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 72. Sanofi S.A. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies